ACE2 is a tissue enzyme and thus circulating levels are low, however, elevated circulating ACE2 is observed in patients with active COVID-19 disease and in the period after infection [58,59] and has been associated with increased risk of major cardiovascular events [60]. The gene discussed is ACE2; the disease is infection.